Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Anukriti Sharma, Mary M. Buschmann, Jack A. Gilbert
Clinical Pharmacology & Therapeutics (2019) Vol. 106, Iss. 2, pp. 317-328
Closed Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Similarity of drug targets to human microbiome metaproteome promotes pharmacological promiscuity
Christopher A. Beaudoin, Shannon Norget, Ziad Omran, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 3
Open Access
Interactions Between the Aging Gut Microbiome and Common Geriatric Giants: Polypharmacy, Frailty, and Dementia
Gizem Gemikonakli, John Mach, Sarah N. Hilmer
The Journals of Gerontology Series A (2020) Vol. 76, Iss. 6, pp. 1019-1028
Closed Access | Times Cited: 31
Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics
Michele Mussap, Cristina Loddo, Claudia Fanni, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 115-134
Closed Access | Times Cited: 29
Potential Drug–Nutrient Interactions of 45 Vitamins, Minerals, Trace Elements, and Associated Dietary Compounds with Acetylsalicylic Acid and Warfarin—A Review of the Literature
Renaud David, Alexander Höller, Miriam Michel
Nutrients (2024) Vol. 16, Iss. 7, pp. 950-950
Open Access | Times Cited: 3
Engineering the Microbiome to Prevent Adverse Events: Challenges and Opportunities
Saad Khan, Ruth Hauptman, Libusha Kelly
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 159-179
Open Access | Times Cited: 27
Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study
Alan K. Jarmusch, Alison Vrbanac, Jeremiah D. Momper, et al.
Clinical and Translational Science (2020) Vol. 13, Iss. 5, pp. 972-984
Open Access | Times Cited: 25
The Microbiome and the Gut‐Liver‐Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models
Kyle G. Hawkins, Thomas Caleb Casolaro, Jacquelyn A. Brown, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 108, Iss. 5, pp. 929-948
Open Access | Times Cited: 25
Enteral Medication for the Tube‐Fed Patient: Making This Route Safe and Effective
Joseph I. Boullata
Nutrition in Clinical Practice (2020) Vol. 36, Iss. 1, pp. 111-132
Closed Access | Times Cited: 24
Microbiome in Behcet's syndrome
Alessandra Bettiol, Giacomo Emmi, Liying Low, et al.
Clinical Immunology (2023) Vol. 250, pp. 109304-109304
Closed Access | Times Cited: 9
Antibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe Drugs
Haijun Yang, Yanjuan Zhang, Rong Zhou, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 4, pp. 509-520
Closed Access | Times Cited: 6
Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?
Ehsan Nobakht, Muralidharan Jagadeesan, Rohan Paul, et al.
Transplantation Direct (2021) Vol. 7, Iss. 2, pp. e650-e650
Open Access | Times Cited: 12
Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects
Sarah‐Jane Leigh, Caoimhe M.K. Lynch, Brian Bird, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 1, pp. 5-26
Open Access | Times Cited: 8
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
Amir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis‐Lorente, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
A Comprehensive Exploration of Microbiota Modulation in Cancer Immunotherapy: Challenges, Opportunities, and Advances
Nathalie Nasser, Ali Hassan, Javeria Hamraa, et al.
(2024)
Open Access | Times Cited: 1
Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut
Khalid El Bairi, Rachid Jabi, Dario Trapani, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 4, pp. 403-421
Open Access | Times Cited: 11
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines
Abdallah Ladaycia, Brigitta Loretz, Catherine Passirani, et al.
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 44-70
Open Access | Times Cited: 11
Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
Sylwia Dzięgielewska-Gęsiak, Edyta Fatyga, Magdalena Piłot, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3589-3599
Open Access | Times Cited: 7
Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance
Lavinia Curini, Amedeo Amedei
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1338-1338
Open Access | Times Cited: 9
Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?
Khalid Mehmood, Afrasim Moin, Talib Hussain, et al.
Folia Microbiologica (2021) Vol. 66, Iss. 6, pp. 897-916
Closed Access | Times Cited: 8
Sex differences in gastrointestinal dysfunction among patients with Parkinson’s disease
Hee Jin Chang, Cheolmin Shin, Jin Whan Cho, et al.
Neurological Sciences (2023) Vol. 44, Iss. 7, pp. 2375-2384
Closed Access | Times Cited: 3
Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy
Lyrialle W. Han, Lu Wang, Yuanyuan Shi, et al.
Drug Metabolism and Disposition (2020) Vol. 48, Iss. 8, pp. 708-722
Open Access | Times Cited: 8
3D In Vitro Human Organ Mimicry Devices for Drug Discovery, Development, and Assessment
Aida Rodríguez‐García, Jacqueline Oliva, C. Flores, et al.
Advances in Polymer Technology (2020) Vol. 2020, pp. 1-41
Open Access | Times Cited: 8
Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Dhwani Rana, Sagar Salave, Akhil Perla, et al.
Current Drug Targets (2022) Vol. 23, Iss. 9, pp. 869-888
Closed Access | Times Cited: 4
Pharmacogenetics: Chasing Perfection
Andrea Gaedigk
Clinical Pharmacology & Therapeutics (2019) Vol. 106, Iss. 2, pp. 265-270
Open Access | Times Cited: 5
The Urgent Need for Management of Biological Samples and Data Accessibility in Latin America
Rodrigo Vargas, Oscar M. Cóbar
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 5

Scroll to top